Biotechs Lose Ground As Achillion Takes a Dive
The Motley Fool
Abbott Declares Dividend and $3 Billion Buyback Plan
The Motley Fool
Why Techne May Be About to Take Off
The Motley Fool
Statement From Sarepta Therapeutics on Stock Volatility
Yahoo/MarketWire
Stryker Increases Dividends, Expands In China
Seeking Alpha

